Pilot Study of the Immunogenicity, Reactogenicity and Tolerability of Two Schedules of a 4CmenB Vaccine in Adolescents and Young Adults
Clinical trial NCT02583412 · COMPLETED
Trial details
- NCT number
- NCT02583412
- Sponsor
- Canadian Immunization Research Network
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.